Election 2014
SENSEX NIFTY

Cancer Drugs

Mar 11, 2014 at 19:10 | Source: CNBC-TV18
Compulsory licence is a tool through which developing countries like India can produce patented drugs, can allow companies to produce patented drugs in a much cheaper and affordable way.
Mar 07, 2014 at 15:27 | Source: CNBC-TV18
Biocon CMD Kiran Mazumdar-Shaw said the companys research efforts are focused on a number of programs that deliver drugs that women can benefit from.
Mar 06, 2014 at 19:45 | Source: Reuters
An Indian committee is reviewing up to a dozen patented drugs to see if so-called compulsory licences, which in effect break exclusivity rights, can be issued for some of them, two senior government officials said last month.
Feb 28, 2014 at 09:29 | Source: Moneycontrol.com
The key drug which is to be studied for epilepsy is Levetiracetam ER. The estimated peak sales at USD 35-50 million and it may be approved by FY16.
Feb 24, 2014 at 13:11 | Source: Moneycontrol.com
Zydus Pharmaceutical USA, a subsidiary of Ahmedabad-based Cadila Healthcare, has received approval from US Food and Drug Administration for Clonidine Hydrochloride injection (with strength of 0.1 MG/ML and 0.5 MG/ML ) on February 20.
Feb 07, 2014 at 22:27 | Source: CNBC-TV18
The Delhi High Court (HC) has thrown a wrench into plans of Biocon and Mylan to market a breast cancer drug that goes by the scientific name Trastuzumab.
Feb 06, 2014 at 15:50 | Source: Reuters
An Indian government committee is reviewing patented drugs of foreign firms to see if so-called compulsory licences, which in effect break exclusivity rights, can be issued for some of them to bring down costs, two senior government officials told Reuters.
Feb 04, 2014 at 09:59 | Source: PTI
The company's subsidiary Mylan Pharmaceuticals Pvt Ltd has launched the world's first trastuzumab biosimilar, which will be marketed by Mylan under the brand name Hertraz Herceptin, a company statement said.
Feb 01, 2014 at 14:25 | Source: CNBC-TV18
Currently there is a trend that the so-called noval combinations are researched because if you use several approaches to tackle cancer, the cancer cells have less of a chance to evade.
Jan 24, 2014 at 08:47 | Source: Moneycontrol.com
Sun Pharma Advanced Research Company (SPARC) announced that its licensee has received an approval from the Drug Controller General of India (DCGI) for Paclitaxel Injection Concentrate for Nanodispersion (PICN), indicated for the treatment of metastatic breast cancer.
Messages on Cancer Drugs »

bkm1974

New Member

2 Followers

Venus Remedies  

wow. On upper circuit. steady increase in qtr sales since last 6 qtr. profit very steady low debt. Still a long way to go. Largest fixed dosage manufacturer. one of better Cancer drug mfr.

1.39 PM Apr 4th

Transgene Biote  

The company is in the final stage for approval of cancer drug once it is done it will be difficult to catch this scrip.

2.48 PM Apr 2nd

babyghost

Platinum Member

37 Followers

Natco Pharma  

after cancer drug approval it be 10000 rs in one year..buy 1 lakh more at 680 today

10.07 AM Apr 1st

pjh

Platinum Member

31 Followers

Anu  

they need a cancer drug as the stock has cancer n is slowly dieing

1.37 PM Mar 28th

Stockie007

New Member

8 Followers

Sun Pharma  

Marketbear,why 500 & why not 700?SP still holds the contract to supply Cancer drug till 2016 & is coming out with new formulae on monthly basis.In fact, in India it is the highest by any drug manufact

12.55 PM Mar 18th

tandonn

Platinum Member

87 Followers

Natco Pharma  

there is a Risk factor which everyone underplays on Natco. No point jumping abt long term nice prdts like cancer drugs for Indian mkt. US market & Copaxone is the big one and there is no ive news. Teva has some success delaying launch & inhlighting need for clinical trials.

11.01 PM Mar 13th

Web Messenger

Platinum Member

208710 Followers

Natco Pharma  

Source:VC Circle - India stunned the pharma industry in 2012 by overriding a valid patent on cancer drug Nexavar from Bayer and issuing a compulsory licence to Natco , allowing the local firm to sell a copy for a fraction of the price. Global drugmakers have had a

11.09 AM Mar 13th

manishnb

Platinum Member

150 Followers

Sun Pharma  

still one product of anti cancer drug going to be approved.

11.04 AM Mar 12th

mudasssar

Silver Member

5 Followers

Sun Pharma  

Sun Pharma is the sole supplier of cancer drug in US and number of patients can be multiple in next 4-5 years so its a good news. first indian company to enter in Japanese markets.Sun Pharma gets US FDA nod for zoledronic acid and diabetic drug as well. Its down because of rupee strengthening

4.22 PM Mar 10th

manishnb

Platinum Member

150 Followers

Sun Pharma  

as expected sp made new high today, unable to sustain. One approval is coming soon for injection of anti cancer drug from FDA.

5.42 PM Mar 3rd

News across the web »
Apr 17, 2014 at 05:45 | Source: FirstPost
Apr 15, 2014 at 14:00 | Source: Bloomberg
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.